Access the latest treatments and medications. unavailable elsewhere - entirely free of charge. We make it easy to take part.
Because of the risk of severe side effects, the US Food and Drug Administration (FDA) has issued a boxed warning for montelukast and recommended that it not be used if any other medications effectively treat the condition.
The boxed warning includes the following statement: “Serious neuropsychiatric events have been reported with the use of montelukast sodium. The types of events reported were highly variable, and included, but were not limited to, agitation, aggression, depression, sleep disturbances, suicidal thoughts and behavior (including suicide).”¹
Prescribers are asked to discuss the risks and benefits with patients before they begin treatment with montelukast. In addition, they are to provide information about how to monitor for changes in behavior, what to look for, and what to do if they occur.
The US FDA has also required a patient medication guide be included to provide more information for those taking montelukast.²
Montelukast is a highly selective leukotriene receptor antagonist. It works by preventing specific leukotrienes from connecting with their receptors. When these leukotrienes bind to the receptors, they trigger the inflammatory process that leads to the symptoms of asthma and allergic rhinitis. By blocking the receptors, montelukast prevents inflammation, reducing the symptoms of asthma, bronchoconstriction, and allergies.³
This medication has been approved by the US FDA to treat the following conditions in adults and children:⁴
Asthma — prevention and chronic treatment (not for acute management)
Bronchoconstriction caused by exercise — prevention (not for acute management)
Seasonal allergic rhinitis (hay fever)
Montelukast is taken orally, and it's available as a film-coated tablet, chewable tablet, and granules in the following strengths:⁵
Tablets: 10mg
Chewable tablets: 4mg, 5mg
Granules: 4mg/packet
You can take this medication with or without food.
Dosage instructions vary by condition and age. Typical recommended doses are detailed below. However, your doctor may prescribe outside the usual range, depending on your condition and personal characteristics.⁶
Use daily for maintenance therapy (not acute asthma episodes)
Best results if used in the evening
Adult and adolescent patients 15 years and older: 10mg
Children 6–14 years: 5mg (chewable)
Children 2–5 years: 4mg (chewable tablet or granule packet)
Children 12–23 months: 4mg (granule packet)
Use at least two hours before planned exercise
Adult and adolescent patients 15 years and older: 10mg
Children 6–14 years: 5mg (chewable)
Not recommended for this indication in children five and under
Use daily during allergy season
May be taken either morning or evening
Adult and adolescent patients 15 years and older: 10mg
Children 6–14 years: 5mg
Children 2–5 years: 4mg (chewable or granule packet)
Children 6–23 months (for year-round indoor allergic rhinitis only): 4mg (granule packet)
Montelukast starts reducing leukotriene levels immediately. However, it may take about a week to effectively combat the symptoms of chronic asthma and allergies.
Taking montelukast two hours before exercising typically provides noticeable results for patients with bronchoconstriction during exercise.
In a 2014 review of the clinical data, montelukast significantly improved the targeted symptoms for both children and adults, even in adults who smoke.⁷
Those with a past adverse or allergic reaction to the medication should not take montelukast. Additionally, people with phenylketonuria should note that the chewable tablet form contains phenylalanine.⁸ ⁹
Side effects have been reported when using montelukast, some of which are seen more frequently than others. The most significant concern is the risk of serious neuropsychiatric events.¹⁰
Common side effects of montelukast include the following:
Headache (most common)
Cough, wheezing
Diarrhea
Ear pain, ear infection
Fatigue
Fever
Rash, hives
Runny nose
Stomach pain
Upper respiratory infection
Rare side effects include the following:
Bruising or rash
Cramps
Dizziness
Drowsiness
Heart palpitations
Inflammation of the pancreas or liver
Joint or muscle pain
Low blood platelet count, leading to increased bleeding
Nose bleed or stuffy nose
Pins and needles or numbness
Montelukast has a US FDA boxed warning because it carries a risk of serious neurologic symptoms and psychiatric events, including the following:¹¹
Aggressive behavior
Agitation, irritability
Anxiety, restlessness
Stuttering
Disorientation, confusion
Hallucinations
Irritability
Sleep problems, nightmares, and sleepwalking
Memory problems
Problems with attention
Suicidal thoughts and actions
Tremor, shaking, and uncontrolled muscle movements
These adverse effects have been seen even in patients who do not have a history of psychiatric disorders. Therefore, patients taking montelukast must be monitored closely for changes in behavior or mood, especially thoughts of suicide. If any of these occur, seek emergency medical care and discontinue using the medication.
High doses of montelukast have been used in clinical studies without serious adverse effects. There have been cases of overdose when children or adults accidentally took doses up to 1,000mg. Signs of an overdose include any of the above symptoms and the following:¹²
Vomiting
Hyperactivity
Sleepiness
Abdominal pain
Headaches
Thirst
In cases of suspected montelukast overdose, discontinue the medication, call the National Poison Control helpline, and seek emergency medical care.
Serious allergic reactions to montelukast are rare. If you experience any combination of the following symptoms of an allergic reaction after taking it, seek emergency medical care.¹³
Hives or blisters
Trouble breathing
Extreme itchiness
Swelling of the lips, face, tongue, or throat
Vomiting
Loss of consciousness
Montelukast is intended to be taken over a long period and is considered safe for long-term use. The drug is not suitable for the treatment of acute episodes.¹⁴
The FDA has designated montelukast as a pregnancy category B medication. Animal studies have shown no evidence of risk with large doses, but there have not been sufficient well-controlled human studies to determine its safety.¹⁵
Studies in humans have not shown an increase in congenital disorders when montelukast has been used during pregnancy, but the trials were not well-controlled. Thus, the risk for the human fetus has not yet been determined.¹⁶
Small amounts of montelukast pass through and get into breastmilk. However, these levels are low and have not been shown to cause harm to the infant.¹⁷
Doctors should discuss the benefits and potential risks with their patients before starting or continuing montelukast during pregnancy and lactation.
If you miss a dose of montelukast, skip it and take your next dose as scheduled. Do not take two doses to make up for the missed one.
A variety of medications interact with montelukast. The interactions range from minor to severe.
Caution is advised when taking the following medications alongside montelukast:¹⁸
Apalutamide (Erleada)
Butalbital (often used in combination products for headaches, such as Fioricet)
Enzalutamide (Xtandi)
Fosphenytoin (Cerebyx)
Ivosidenib (Tibsovo)
Lumacaftor/ivacaftor (Orkambi)
Mitotane (Lysodren)
Pentobarbital (Nembutal)
Phenobarbital (Solfoton, Luminal)
Primidone (Mysoline)
Rifabutin (Mycobutin)
Rifampin (Rifadin, Rimactane)
St. John’s wort
There are no known restrictions for drinking alcohol while taking montelukast.
Montelukast is available by prescription only, so you’ll need to meet with your doctor before you start taking it. At your appointment, you should discuss the following:
All medications, supplements, or herbs you take regularly or occasionally
Any allergies or allergic reactions you’ve had to medicines
Any personal or family history of mental illness
If you have phenylketonuria
Any other medical conditions you have, such as liver disease
If you are pregnant or plan to become pregnant
If you are breastfeeding or plan to breastfeed
In general, patients should continue taking montelukast until a doctor advises them to stop. However, there are no expected withdrawal concerns with discontinuing use.
If you experience mood or behavior changes while taking montelukast, stop using it immediately and consult your prescriber.
1998: The US FDA grants initial approval
2007: The manufacturer adds a warning to the drug’s prescribing information to address the risk of psychiatric issues
2020: The US FDA requires a boxed warning regarding the potential for adverse psychiatric effects
Do not stop using a rescue inhaler when needed if you are taking montelukast for asthma. It is exclusively preventative and is not an appropriate treatment for acute asthma attacks.
When giving granules to children, don’t open the packet until it is time to give the dose. You can pour them directly into the child’s mouth or place them on a spoon. Additionally, and particularly for infants, you may mix them with a teaspoon of formula, applesauce, or breast milk. Dispose of any unused, opened portions.²⁰
If you experience any psychiatric symptoms, discontinue use immediately and contact your doctor or seek emergency medical care.
Some people may feel tired after taking montelukast. Avoid driving or operating heavy machinery until you know how the drug affects you.
Some of the mild side effects from the medication may resolve without intervention. However, if you or the people close to you notice changes in your mood or behavior, don’t wait to see if these side effects will improve. Instead, stop using the medication immediately and see your doctor.
Although serious side effects are uncommon, the US FDA considers some of them so severe that it issued a boxed warning. Because of these dangers, it's recommended that montelukast be taken only if no other medication is tolerated or provides adequate symptom relief.
Sources
Montelukast- montelukast tablet, film coated | NIH DailyMed
FDA requires boxed warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); Advises restricting use for allergic rhinitis | U.S. Food and Drug Administration
Montelukast (2022)
(As above)
Phenylketonuria | NIH MedlinePlus
FDA requires boxed warning about serious mental health side effects for asthma and allergy drug montelukast (singulair); advises restricting use for allergic rhinitis | U.S. Food & Drug Administration
Montelukast | NIH MedlinePlus
Pregnancy medications (2022)
Montelukast (Rx) | Medscape
(As above)
FDA requires stronger warning about risk of neuropsychiatric events associated with asthma and allergy medication singulair and generic montelukast | U.S. Food & Drug Administration
Montelukast | NIH MedlinePlus
Access the latest treatments and medications. unavailable elsewhere - entirely free of charge. We make it easy to take part.
Here at HealthMatch, we’ve done our best to ensure that the information provided in this article is helpful, up to date, and, most importantly, accurate.
However, we can’t replace the one-to-one advice of a qualified medical practitioner or outline all of the possible risks associated with this particular drug and your circumstances.
It is therefore important for you to note that the information contained in this article does not constitute professional medical or healthcare advice, diagnosis or recommendation of treatment and is not intended to, nor should be used to, replace professional medical advice. This article may not always be up to date and is not exhaustive of all of the risks and considerations relevant to this particular drug. In no circumstances should this article be relied upon without independent consideration and confirmation by a qualified medical practitioner.
Your doctor will be able to explain all possible uses, dosages, precautions, interactions with other drugs, and other potential adverse effects, and you should always talk to them about any kind of medication you are taking, thinking about taking or wanting to stop taking.
Access the latest treatments and medications. unavailable elsewhere - entirely free of charge. We make it easy to take part.